CN104418767A - Demeclocycline extraction process - Google Patents
Demeclocycline extraction process Download PDFInfo
- Publication number
- CN104418767A CN104418767A CN201310380480.4A CN201310380480A CN104418767A CN 104418767 A CN104418767 A CN 104418767A CN 201310380480 A CN201310380480 A CN 201310380480A CN 104418767 A CN104418767 A CN 104418767A
- Authority
- CN
- China
- Prior art keywords
- cicloxin
- extraction process
- demeclocycline
- filtrate
- concentrated solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a demeclocycline extraction process which comprises the following technical steps: adding an antioxidant into demeclocycline fermentation liquor, adjusting the pH to 1.0-4.0 by an acid, micro-filtering to separate mycelia and other solid impurities, and decolorizing the filtrate; concentrating the decolorized filtrate by using a nanofiltration organic film to obtain a demeclocycline concentrated solution; adjusting the pH of the concentrated solution to 4.5-8.5 by an alkali, carrying out crystallization and sedimentation, and carrying out solid-liquid separation on precipitate to obtain a demeclocycline crude product; and refining the demeclocycline crude product by using a double salt method to obtain a demeclocycline hydrochloride finished product. Compared with the original solvent extraction process, the process provided by the invention avoids use of organic solvents or greatly reduces use of organic solvents, so that discharge of three wastes is less and the environmental pollution is reduced. The process is stable in product yield and quality and suitable for industrial production and has a very high practical value. The obtained product meets EP and USP standards.
Description
Technical field
The present invention relates to the preparation of medicine, particularly relate to a kind of novel technology for extracting of cicloxin.
Background technology
Cicloxin, another name Demethylchlortetracycline, demethyl Uromycin etc., be the tetracycline antibiotics produced by streptomyces aureus fermentation, similar to duomycin for its antimicrobial spectrum of bulk drug, antibacterial effect is stronger than tsiklomitsin, stablizes than duomycin.Along with derivative Minocycline HCl and Tigecycline are gone on the market and the Persisting exploitation of other derivatives in succession, the market outlook of cicloxin are more and more wide.
Traditional cicloxin fermentative production extracting method is filter after cicloxin fermented liquid is carried out pre-treatment, sheet frame, filtrate uses N-BUTYL ACETATE and butanols to extract, then use hydrochloric acid to strip and concentrate recrystallize, oven dry obtains cicloxin hydrochloride, traditional technology uses a large amount of N-BUTYL ACETATEs and butanols, and two solvents all have very high water-soluble, so three waste discharge is serious, environmental treatment cost increases; And due to the complicacy of fermented liquid and organic solvent extraction limitation, cause extraction difficulty, quality product and yield are all subject to Different Effects.
Summary of the invention
The present invention is intended to overcome the above problems, and spy provides a kind of cicloxin extraction process, and it comprises following processing step;
A, in cicloxin fermented liquid, add oxidation inhibitor, through acid for adjusting pH=1.0-4.0, micro-filtration, isolates mycelium and other solid impurities, and filtrate is decoloured;
B, destainer concentrate through nanofiltration organic membrane, obtain cicloxin concentrated solution;
C, concentrated solution is regulated pH=4.5-8.5 through alkali, crystalline deposit, to precipitate after solid-liquid separation to obtain cicloxin crude product;
D, cicloxin double salt method to be refined, obtain cicloxin hydrochloride finished product.
Wherein antioxidant is 0.05-0.5wt% S-WAT, and wherein acid is hydrochloric acid or oxalic acid, and wherein use ceramic membrane to carry out micro-filtration, wherein filtrate is decoloured through decolorizing resin.
Wherein nanofiltration organic membrane molecular weight cut-off is 100-500 dalton, and wherein alkali is NaOH solution or the ammoniacal liquor of 0.1-2M.
Wherein cicloxin uses urea double salt method or calcium magnesium double salt method to refine.
Compared with traditional solvent extraction method, the present invention uses ceramic membrane filter, resin decolorization, organic membrane filter concentrated, then NaOH solution or ammoniacal liquor is directly used by concentrated solution to regulate pH to carry out crystalline deposit, re-use urea double salt method or calcium magnesium double salt method carries out being refined into cicloxin hydrochloride, thus avoid or greatly reduce with an organic solvent, greatly reduce environmental pollution, thus produce good economic benefit and social benefit.And decolouring is concentrated is physical means, and quality product and yield all have stable guarantee.
Embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment one
By the fermented liquid containing 6.0g/L cicloxin 35 liters, adjust the temperature to 5-10 DEG C and add 0.05wt% S-WAT 35g, adjust the temperature to 10 DEG C, oxalic acid is used to regulate pH=1.5 ± 0.2, stir 20 minutes, use Nanjing for a long time my company's ceramic membrane filter, pottery membrane flux 30 ls/h; Obtain filtrate 70 liters;
Filtrate is crossed 122 resins, flow velocity 2BV/h, use the tap water top of pH=6.8-7.0 to wash 0.5 hour after completing, obtain destainer 72 liters;
Destainer being crossed molecular weight cut-off is 150 GE company of daltonian U.S. organic nanofiltration membrane assemblies, pressure 1.5mpa, and temperature keeps 5-10 DEG C; Obtain concentrated solution 4 liters;
By under concentrated solution agitation condition, regulate temperature 5-8 DEG C, use the ammoniacal liquor of 0.1M to regulate pH=6.5 ± 0.2, be precipitated suspension, continue stirring 30 minutes, leave standstill 30 minutes, solid-liquid separation obtains cicloxin crude product;
Used by cicloxin crude product urea double salt method to refine to obtain cicloxin finished product, dry to obtain cicloxin hydrochloride 152g, total recovery 72.38%; Finished product censorship meets EP, USP standard.
Embodiment two
By the fermented liquid containing 7.5g/L cicloxin 30 liters, add 0.5wt% S-WAT 150g, adjust the temperature to 5-10 DEG C, hydrochloric acid is used to regulate pH=2.5 ± 0.2, stir 20 minutes, use Xiamen three to reach company's ceramic membrane filter, pottery membrane flux 24.5 ls/h; Obtain filtrate 65 liters;
Filtrate is crossed LX-200 resin decolorization, flow velocity 3BV/h, use the tap water top of pH=6.8-7.0 to wash 0.5 hour after completing, obtain destainer 70 liters;
Destainer being crossed molecular weight cut-off is 150 GE company of daltonian U.S. organic nanofiltration membrane assemblies, pressure 1.5mpa, and temperature keeps 5-10 DEG C; Obtain concentrated solution 3.8 liters;
By under concentrated solution agitation condition, regulate temperature 5-8 DEG C, use the NaOH aqueous solution of 2M to regulate pH=8.2 ± 0.2, be precipitated suspension, continue stirring 30 minutes, leave standstill 30 minutes, solid-liquid separation obtains cicloxin crude product;
Used by cicloxin crude product urea double salt method to refine to obtain cicloxin finished product, dry to obtain cicloxin hydrochloride 166g, total recovery 73.78%; Finished product censorship meets EP, USP standard.
Embodiment three
By the fermented liquid containing 5.8g/L cicloxin 30 liters, adjust the temperature to 5-10 DEG C, add 0.1wt% S-WAT 30g, oxalic acid is used to regulate pH=3.8 ± 0.2, stir 20 minutes, use Nanjing for a long time my company's ceramic membrane filter, pottery membrane flux 28.5 ls/h; Obtain filtrate 70 liters;
Filtrate is crossed ROHM AND HAAS decolorizing resin, flow velocity 4BV/h, use the tap water top of pH=6.8-7.0 to wash 0.5h after completing, obtain destainer 75 liters;
Destainer being crossed molecular weight cut-off is 100 GE company of daltonian U.S. organic nanofiltration membrane assemblies, pressure 1.8mpa, and temperature keeps 5-10 DEG C; Obtain concentrated solution 4.5 liters;
By under concentrated solution agitation condition, regulate temperature 5-8 DEG C, use the ammoniacal liquor of 1M to regulate pH=4.8 ± 0.2, be precipitated suspension, continue stirring 30 minutes, leave standstill 30 minutes, solid-liquid separation obtains cicloxin crude product;
Used by cicloxin crude product calcium magnesium double salt method to refine to obtain cicloxin finished product, dry to obtain cicloxin hydrochloride 127g, total recovery 72.98%; Finished product censorship meets EP, USP standard.
Claims (8)
1. a cicloxin extraction process, is characterized in that comprising following processing step;
A, in cicloxin fermented liquid, add oxidation inhibitor, through acid for adjusting pH=1.0-4.0, micro-filtration, isolates mycelium and other solid impurities, and filtrate is decoloured;
B, destainer concentrate through nanofiltration organic membrane, obtain cicloxin concentrated solution;
C, concentrated solution is regulated pH=4.5-8.5 through alkali, crystalline deposit, to precipitate after solid-liquid separation to obtain cicloxin crude product;
D, cicloxin double salt method to be refined, obtain cicloxin hydrochloride finished product.
2. cicloxin extraction process as claimed in claim 1, wherein antioxidant is 0.05-0.5wt% S-WAT.
3. cicloxin extraction process as claimed in claim 1, wherein acid is hydrochloric acid or oxalic acid.
4. cicloxin extraction process as claimed in claim 1, wherein carries out micro-filtration by ceramic membrane.
5. cicloxin extraction process as claimed in claim 1, wherein the molecular weight cut-off of nanofiltration organic membrane is 100-500 dalton.
6. cicloxin extraction process as claimed in claim 1, wherein alkali is NaOH solution or the ammoniacal liquor of 0.1-2M.
7. cicloxin extraction process as claimed in claim 1, wherein cicloxin uses urea double salt method or calcium magnesium double salt method to refine.
8. cicloxin extraction process as claimed in claim 1, wherein filtrate is decoloured through decolorizing resin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310380480.4A CN104418767A (en) | 2013-08-28 | 2013-08-28 | Demeclocycline extraction process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310380480.4A CN104418767A (en) | 2013-08-28 | 2013-08-28 | Demeclocycline extraction process |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104418767A true CN104418767A (en) | 2015-03-18 |
Family
ID=52968976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310380480.4A Pending CN104418767A (en) | 2013-08-28 | 2013-08-28 | Demeclocycline extraction process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104418767A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108147976A (en) * | 2016-12-06 | 2018-06-12 | 上海医药工业研究院 | A kind of extracting method Ledermycined |
CN108191692A (en) * | 2017-12-25 | 2018-06-22 | 安徽永生堂药业有限责任公司 | A kind of process for separation and purification of tetracycline antibiotics |
CN114848599A (en) * | 2022-06-09 | 2022-08-05 | 驻马店华中正大有限公司 | High-stability aureomycin premix and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3375276A (en) * | 1963-06-24 | 1968-03-26 | Squibb & Sons Inc | Method for preparing tetracycline products |
US3433709A (en) * | 1965-12-07 | 1969-03-18 | American Cyanamid Co | Biological transformation of alpha-6-deoxytetracyclines to tetracyclines |
CN1590368A (en) * | 2003-09-04 | 2005-03-09 | 华北制药集团有限责任公司 | Recovery method of demeclocy cline hydrochloride crystal mother liquor |
CN102731340A (en) * | 2011-04-15 | 2012-10-17 | 河南天方药业股份有限公司 | Preparation method of demethyl aureomycin hydrochloride |
-
2013
- 2013-08-28 CN CN201310380480.4A patent/CN104418767A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3375276A (en) * | 1963-06-24 | 1968-03-26 | Squibb & Sons Inc | Method for preparing tetracycline products |
US3433709A (en) * | 1965-12-07 | 1969-03-18 | American Cyanamid Co | Biological transformation of alpha-6-deoxytetracyclines to tetracyclines |
CN1590368A (en) * | 2003-09-04 | 2005-03-09 | 华北制药集团有限责任公司 | Recovery method of demeclocy cline hydrochloride crystal mother liquor |
CN102731340A (en) * | 2011-04-15 | 2012-10-17 | 河南天方药业股份有限公司 | Preparation method of demethyl aureomycin hydrochloride |
Non-Patent Citations (1)
Title |
---|
褚志义等: "《生物合成药物学》", 31 May 1991 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108147976A (en) * | 2016-12-06 | 2018-06-12 | 上海医药工业研究院 | A kind of extracting method Ledermycined |
CN108147976B (en) * | 2016-12-06 | 2020-11-10 | 上海医药工业研究院 | Extraction method of demethylated aureomycin |
CN108191692A (en) * | 2017-12-25 | 2018-06-22 | 安徽永生堂药业有限责任公司 | A kind of process for separation and purification of tetracycline antibiotics |
CN114848599A (en) * | 2022-06-09 | 2022-08-05 | 驻马店华中正大有限公司 | High-stability aureomycin premix and preparation method thereof |
CN114848599B (en) * | 2022-06-09 | 2023-10-13 | 驻马店华中正大有限公司 | High-stability aureomycin premix and preparation method thereof |
WO2023236507A3 (en) * | 2022-06-09 | 2024-02-01 | 驻马店华中正大有限公司 | Highly stable chlortetracycline premix and preparation method therefor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102976923B (en) | New process for extracting lactic acid from lactic acid fermentation liquid | |
CN108822163B (en) | Comprehensive cyclic production method of D-glucosamine hydrochloride | |
CN102746348A (en) | Method for separation of lincomycin | |
CN109180749B (en) | Method for preparing high-purity N-acetylneuraminic acid hydrate by using supersaturation crystallization method | |
CN103102384B (en) | Method for extracting high-purity ursolic acid from rosemary | |
CN104418767A (en) | Demeclocycline extraction process | |
CN109081844B (en) | Method for extracting spectinomycin from fermentation culture | |
WO2018192529A1 (en) | Method for preparing s-abscisic acid | |
CN110790805A (en) | Method for extracting chenodeoxycholic acid from pig bile paste | |
CN102603478B (en) | Method for separating and purifying erythritol from mother liquid obtained after repeated crystallization of erythritol | |
CN101407533B (en) | Method for producing abomacetin rhodanate | |
CN113583064B (en) | Process method for producing rebaudioside B by high-temperature pyrolysis method | |
CN109553645B (en) | Method for extracting low-content erythromycin A in fermentation solution | |
CN107383135A (en) | The method that β thymidines are isolated and purified from zymotic fluid | |
CN111269181B (en) | Method and device for purifying sinomenine hydrochloride | |
CN104497076A (en) | Preparation purification method for high-purity geniposide | |
CN107129456B (en) | Production process for extracting L-tryptophan from fermentation liquor | |
CN103012509B (en) | Method of separating and purifying sucrose-6-acetate mother liquor by salt fractionation | |
CN113429283B (en) | Method for recovering phenylacetic acid from medical wastewater | |
CN112047961B (en) | Method for separating and crystallizing 6-aminopenicillanic acid from penicillin enzymolysis liquid | |
CN103058858A (en) | Method for extracting high-purity carnosic acid from rosemary | |
CN110452275B (en) | Preparation method of high-purity kasugamycin | |
CN110606844B (en) | Mupirocin purification method | |
CN104151275B (en) | The preparation method of Andrographolide compound | |
CN107586310B (en) | Extraction process of flavomycin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150318 |